Providing options to facilitate high complex community-based care through the provision of Outpatient Parenteral Antimicrobial Therapy (OPAT) solutions.
A solutions oriented medical device company developing an IV therapy platform technology that enables high quality, sustainable healthcare services and directly facilitates the attainment of global health goals and provides solutions against emerging high priority public health threats. Our technology platform solution will revolutionize the delivery of IV therapies in order to address infectious diseases and the global threat of Anti-Microbial Resistance (AMR).
Providing options to facilitate high complex community-based care through the provision of Outpatient Parenteral Antimicrobial Therapy (OPAT) solutions.
Introducing cost effective solutions enabling sustainability of healthcare systems, whilst enhancing the safety and Quality of Life (QoL) for patients.
Optimizing the choice and dosing of antibiotics in order to deliver positive clinical outcomes and enhance stewardship.